OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel epigenetic therapeutic strategies and targets in cancer
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166552-166552
Open Access | Times Cited: 30
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166552-166552
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Unraveling host regulation of gut microbiota through the epigenome–microbiome axis
Michael Le Pepke, Søren B. Hansen, Morten T. Limborg
Trends in Microbiology (2024) Vol. 32, Iss. 12, pp. 1229-1240
Open Access | Times Cited: 18
Michael Le Pepke, Søren B. Hansen, Morten T. Limborg
Trends in Microbiology (2024) Vol. 32, Iss. 12, pp. 1229-1240
Open Access | Times Cited: 18
DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma
Yangfan Liu, Yu Sun, Jin Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Yangfan Liu, Yu Sun, Jin Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
Mengchen Xu, Yiming Hou, Na Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Mengchen Xu, Yiming Hou, Na Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs
Deepa Bhartiya, Sherif Raouf, Kshama Pansare, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 4, pp. 857-880
Closed Access | Times Cited: 6
Deepa Bhartiya, Sherif Raouf, Kshama Pansare, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 4, pp. 857-880
Closed Access | Times Cited: 6
An updated patent review of BRD4 degraders
Zonghui Ma, Cun Zhang, Andrew A. Bolinger, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 929-951
Closed Access | Times Cited: 6
Zonghui Ma, Cun Zhang, Andrew A. Bolinger, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 929-951
Closed Access | Times Cited: 6
Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers
Zahra Heydari, Farideh Moeinvaziri, Seyed Mohammad Ali Mirazimi, et al.
European Journal of Pharmacology (2024) Vol. 973, pp. 176563-176563
Closed Access | Times Cited: 5
Zahra Heydari, Farideh Moeinvaziri, Seyed Mohammad Ali Mirazimi, et al.
European Journal of Pharmacology (2024) Vol. 973, pp. 176563-176563
Closed Access | Times Cited: 5
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics
Nazanin Zohourian, James A. L. Brown
Epigenomics (2024) Vol. 16, Iss. 9, pp. 671-680
Closed Access | Times Cited: 5
Nazanin Zohourian, James A. L. Brown
Epigenomics (2024) Vol. 16, Iss. 9, pp. 671-680
Closed Access | Times Cited: 5
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy
Jaewang Lee, Jong‐Lyel Roh
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1605-1623
Closed Access | Times Cited: 12
Jaewang Lee, Jong‐Lyel Roh
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1605-1623
Closed Access | Times Cited: 12
DNMT3a promotes LUAD cell proliferation and metastasis by activating the HDAC7 signalling pathway
Menglong Jiang, Xin Zhou, Yingtong Feng, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 4, pp. 1585-1602
Open Access
Menglong Jiang, Xin Zhou, Yingtong Feng, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 4, pp. 1585-1602
Open Access
The role of lactylation in tumor growth and cancer progression
Khulood Al-Malsi, Sinan Xie, Yunshi Cai, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Khulood Al-Malsi, Sinan Xie, Yunshi Cai, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Harnessing omics data for drug discovery and development in ovarian aging
Fengyu Zhang, Ming Zhu, Yi Chen, et al.
Human Reproduction Update (2025)
Closed Access
Fengyu Zhang, Ming Zhu, Yi Chen, et al.
Human Reproduction Update (2025)
Closed Access
Epigenetic drugs in cancer therapy
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Isothiocyanates Enhance the Anti-Melanoma Effect of Zebularine Through Modulation of Apoptosis and Regulation of DNMTs’ Expression, Chromatin Configuration and Histone Posttranslational Modifications Associated with Altered Gene Expression Patterns
Ioannis Anestopoulos, Ioannis Paraskevaidis, Sotiris Kyriakou, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 7-7
Open Access
Ioannis Anestopoulos, Ioannis Paraskevaidis, Sotiris Kyriakou, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 7-7
Open Access
Unravelling the epigenetic based mechanism in discovery of anticancer phytomedicine: Evidence based studies
Bushra Bashir, Pranshul Sethi, Satyajit Panda, et al.
Cellular Signalling (2025), pp. 111743-111743
Closed Access
Bushra Bashir, Pranshul Sethi, Satyajit Panda, et al.
Cellular Signalling (2025), pp. 111743-111743
Closed Access
Insights on metabolic connections and interplay between cancer and diabetes: role of multi-target drugs
Angeline Julius, Suresh Malakondaiah, Raghu Babu Pothireddy
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Angeline Julius, Suresh Malakondaiah, Raghu Babu Pothireddy
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
PAQR4: From spatial regulation of cell signaling to physiological homeostasis and diseases
Z.-K. Jin, Zhi‐Qiang Ling
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189314-189314
Closed Access
Z.-K. Jin, Zhi‐Qiang Ling
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189314-189314
Closed Access
Methylation of
Fengna Liu, Aiai Gao, Meiying Zhang, et al.
PubMed (2024) Vol. 12, Iss. 3, pp. 274-287
Closed Access | Times Cited: 3
Fengna Liu, Aiai Gao, Meiying Zhang, et al.
PubMed (2024) Vol. 12, Iss. 3, pp. 274-287
Closed Access | Times Cited: 3
Landscape of targeted therapies for lung squamous cell carcinoma
Qiuxuan Chen, Xiao-Shuo Zheng, Weiting Cheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Qiuxuan Chen, Xiao-Shuo Zheng, Weiting Cheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Cytotoxic Activity of Amaryllidaceae Plants against Cancer Cells: Biotechnological, In Vitro, and In Silico Approaches
Lina M. Trujillo Chacón, Janeth Bedoya, Natalie Cortés, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2601-2601
Open Access | Times Cited: 7
Lina M. Trujillo Chacón, Janeth Bedoya, Natalie Cortés, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2601-2601
Open Access | Times Cited: 7
Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment
Wenqiang Li, Quan Yuan, Mei Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Wenqiang Li, Quan Yuan, Mei Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Promise of dostarlimab in cancer therapy: Advancements and cross-talk considerations
Quratulain Babar, Ayesha Saeed, Sivasubramanian Murugappan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103577-103577
Open Access | Times Cited: 4
Quratulain Babar, Ayesha Saeed, Sivasubramanian Murugappan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103577-103577
Open Access | Times Cited: 4
A Computational Approach for the Discovery of Novel DNA Methyltransferase Inhibitors
Eftichia Kritsi, Paris Christodoulou, Thalia Tsiaka, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3394-3407
Open Access | Times Cited: 1
Eftichia Kritsi, Paris Christodoulou, Thalia Tsiaka, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3394-3407
Open Access | Times Cited: 1
From microscopes to molecules: The evolution of prostate cancer diagnostics
Junyue Tao, Xiaokang Bian, Jun Zhou, et al.
CytoJournal (2024) Vol. 21, pp. 29-29
Open Access | Times Cited: 1
Junyue Tao, Xiaokang Bian, Jun Zhou, et al.
CytoJournal (2024) Vol. 21, pp. 29-29
Open Access | Times Cited: 1
